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Acute normovolemic hemodilution and
intraoperative cell salvage in aortic surgery
Francesco Torella, FRCS, Sarah L. Haynes, PhD, Cliona C. Kirwan, FRCS, Anand N. Bhatt, and
Charles N. McCollum, FRCS, Manchester, United Kingdom
Objective: The objective of this study was to report current transfusion requirements and outcomes in patients under-
going elective aortic surgery with autologous transfusion.
Methods: This was a retrospective review of transfusion practice in infrarenal aortic surgery in a tertiary vascular unit
with a longstanding interest in autologous transfusion. One hundred and ten consecutive patients underwent infrarenal
aortic surgery with a combination of acute normovolemic hemodilution (ANH) and intraoperative cell salvage (ICS). All
patients underwent hemodilution to a target hemoglobin concentration of 11 g/dL and underwent ICS with a
centrifugal device.
Results: Median blood loss was 1140 mL (interquartile range [IQR], 683 to 1609 mL) in 78 aneurysm repairs and 775
mL (IQR, 400 to 1225 mL) in 32 aortobifemoral bypasses for occlusive disease (P .02), resulting in a median salvaged
red cell volume of 403 mL (IQR, 256 to 563 mL) for aneurysm repairs and 250 mL (IQR, 200 to 290 mL) in bypass
surgery (P  .001). Thirty-six patients (33%) needed transfusion of stored blood, for a total of 115 units, with just four
patients needing more than five units. The mortality rate was 8% (9/110). With multivariate analysis, low hemoglobin
level (P  .006) and low platelet count (P  .023) were associated with stored blood transfusion.
Conclusion: Blood loss is too small to justify ICS in surgery for occlusive disease; ANH alone may be a suitable strategy.
With appropriate experience, the combination of ANH and ICS may render crossmatching unnecessary, even in aortic
aneurysm surgery. (J Vasc Surg 2002;36:31-4.)
Autologous transfusion is becoming increasingly pop-
ular in blood conservation strategies and, in Britain, has
been prioritized by the National Health Service.1 Because
aortic surgery is associated with significant blood loss, the
use of autologous transfusion, intraoperative cell salvage
(ICS) especially, has been frequently reported.2-5 How-
ever, some controversy exists about the efficacy of ICS in
aortic surgery, with three randomized trials showing signif-
icant reductions in allogeneic transfusion6-8 and one show-
ing little benefit.9 Other autologous transfusion techniques
are less popular in vascular surgery, and acute normovo-
lemic hemodilution (ANH) in particular is rarely used.10,11
In a recent multicenter trial performed by our unit, the
combination of ANH and ICS significantly reduced expo-
sure to allogeneic blood during and after aortic surgery.8
However, allogeneic blood requirements in this trial were
substantial even with autologous transfusion, with signifi-
cant variation among participating centers. Because we
routinely use ANH and ICS, we decided to review our
experience with this transfusion strategy in infrarenal aortic
surgery. The aim of this work was to report allogeneic
blood use in a unit with a keen interest in blood conserva-
tion strategies.
METHODS
We have maintained a prospective database on autolo-
gous blood transfusion since 1995. This database was
searched for all records on patients who underwent aortic
surgery in South Manchester University Hospital under the
care of a single consultant surgeon from January 1995 to
February 2001. Demographics, details of surgery, and trans-
fusion requirements were all recorded. Data collection was
completed with a retrospective review of hospital records to
confirm patient characteristics and clinical outcome.
Autologous transfusion. Autologous transfusion was
performed according to a standard protocol.
Acute normovolemic hemodilution. Before skin in-
cision, sufficient blood was taken to reduce the hemoglobin
concentration to 11 g/dL. The amount of blood to be
removed was calculated with the following formula12:
(Hb  11)/[(Hb  11)/2]  blood volume, with Hb
representing hemoglobin.
Blood volume was calculated before surgery from
height and weight with standard nomograms.13 Blood was
collected from central venous lines into bags containing
citrate-phosphate-dextrose-adenine-1 anticoagulant, la-
beled according to published guidelines12 and replaced
simultaneously with a peripheral infusion of crystalloids at a
3:1 volume ratio. ANH was directed by the anesthetist,
who controlled the rate of bleeding according to heart rate,
arterial pressure, and electrocardiographic monitoring.
Cell salvage. Blood lost during surgery was salvaged
with a centrifugal cell salvage device (Haemonetics Cell
Saver 3 or 5, Haemonetics, United Kingdom; or Fresenius
CATS, Fresenius, Germany), washed, and reinfused. All
swabs were washed in heparinized saline solution (50
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units/mL), which then was processed with the cell salvage
device. Five thousand units of heparin were given routinely
before aortic cross clamping and were not reversed at the
end of the procedure.
Blood losses were calculated from suction reservoirs;
blood lost to drapes was estimated visually by the cell
salvage operator in each case. Autologous blood was always
reinfused within 6 hours of collection.12 If transfusion was
needed during surgery, salvaged red cells were given first.
After reinfusion of salvaged red cells, allogeneic transfusion
was given only when the hemoglobin concentration fell
below 8 to 8.5 g/dL or when unstable vital signs (in
particular ST segment depression on electrocardiographic
monitoring) persisted despite correction of hypovolemia.
ANH blood was reserved for reinfusion at wound closure
(after reinfusion of salvaged red cells and, if necessary,
allogeneic blood transfusion) to replenish platelets and
clotting factors when most needed.
Analysis of results. All data were tabulated in a com-
puter file and analyzed with statistical software (SPSS 9,
SPSS Inc, Chicago, Ill). Continuous variables were pre-
sented with medians and interquartile ranges (IQRs) and
compared with the nonparametric Mann-Whitney U test.
Proportions were compared with the 2 test or the Fisher
exact test. Stepwise logistic regression was used to identify
predictors of the need for allogeneic transfusion. Covariates
in this analysis were hemoglobin concentration, platelet
count, type of aortic disease (aneurysmal or occlusive),
aspirin intake, and intraoperative blood loss.
RESULTS
Patients. Two hundred and twenty-one patients who
underwent elective aortic surgery from January 1995 to
February 2001 were identified. Of these, 111 were ex-
cluded from the analysis for the following reasons: 44
underwent complex reconstructions (suprarenal or thora-
coabdominal aneurysms; replacement of aortic grafts, com-
bined procedures); 33 were recruited in trials on different
transfusion strategies; 31 underwent ICS only, because of a
suspected contained rupture or low preoperative hemoglo-
bin (precluding collection of at least 1 unit of blood accord-
ing to the formula reported previously); and three cases had
no medical records available for review. One hundred and
ten patients underwent ANH and ICS during either aneu-
rysm repair (n 78) or aortobifemoral bypass for occlusive
aortic disease (n  32). Sixty men and 18 women, with a
median age of 72 years (IQR, 67 to 77 years) underwent
aneurysm repair, and 23 men and nine women, with a
median age of 65 years (IQR, 52 to 71 years), underwent
surgery for occlusive disease.
Median preoperative hemoglobin concentration was
13.8 g/dL (IQR, 12.9 to 14.8 g/dL), and platelet count
was 228109/L (IQR, 193 to 280109/L). For patients
with an aortic aneurysm, the median aneurysm size was 6.0
cm (IQR, 5.7 to 7.0 cm). Comorbidities and smoking
habits were summarized in Table I. Median procedure time
(including anesthetic and operating times) was 165 min-
utes (IQR, 135 to 210 minutes) in aneurysm repairs and
188 minutes (IQR, 170 to 240 minutes) in surgery for
occlusive disease. Ten patients needed a suprarenal clamp
during aneurysm repair, and only one needed one during
aortobifemoral bypass for occlusive disease.
Blood volumes. The median blood volume was 4840
mL (IQR, 4097 to 5180 mL) in patients who underwent
aneurysm repair and 4699 mL (IQR, 3573 to 4981 mL) in
those who underwent aortobifemoral bypass for occlusive
disease. Before skin incision, 1 to 4 units of blood were
collected from each patient during ANH. Blood losses and
salvaged red cell volumes were significantly lower in pa-
tients who underwent aortobifemoral bypass for occlusive
disease (Table II). Allogeneic blood was not necessitated in
74 cases (67%), with only 115 units transfused to 36
patients (33%; Table II). Of these, 29 had aneurysms and
seven had occlusive aortic disease (P  .18); the overall
median transfusion requirement was 0 units (IQR, 0 to 2
units). Only four patients, all undergoing aneurysm repair,
needed more than 5 units of stored blood. There appeared
to be a learning effect because the last 61 consecutive
patients completely avoided stored blood transfusion dur-
ing surgery. Logistic regression identified only two protec-
tive factors against stored blood transfusion: high preoper-
ative hemoglobin (odds ratio, 0.5; 95% confidence interval,
0.35 to 0.84 for a 1 g/dL increase; P  .006) and high
platelet count (odds ratio, 0.6; 95% confidence interval,
0.41 to 0.94 for a 50  109/L increase; P  .023). Blood
loss, aspirin intake, or type of aortic disease (aneurysm or
occlusive) did not predict the need for allogeneic transfu-
sion in our patients. Transfusion of other blood products
was uncommon: 5 units of platelets were necessary in two
cases, and four patients needed a total of 21 units of fresh
frozen plasma. Postoperative outcome is summarized in
Table III. Unsurprisingly, the 11 patients needing further
surgery had large allogeneic blood requirements: 3 units (0
to 6 units) compared with 0 units (0 to 1 units) when
reoperation was not necessary (P  .001). Furthermore,
the 65 patients with uneventful postoperative recoveries
only needed a total of 33 units. On discharge, the median
hemoglobin concentration was 11.4 g/dL (IQR, 10.4 to
12.3 g/dL) and the platelet count was 291 109/L (IQR,
212 to 388  109/L). The median hemoglobin concen-
Table I. Preoperative risk factors
AAA
(n  78)
ABG
(n  32)
Cardiac disease 38 (49%) 7 (28%)
Pulmonary disease 12 (15%) 5 (16%)
Hypertension 29 (37%) 11 (34%)
Diabetes 5 (6%) 4 (13%)
Renal impairment 3 (4%) 0
Stroke/TIAs 7 (9%) 3 (9%)
Smokers
Never 13 (17%) 4 (12%)
Former 25 (32%) 14 (44%)
Current 52 (50%) 14 (44%)
AAA, aneurysm repair; ABG, aortobifemoral bypass; TIA, transient is-
chemic attack.
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tration was 11.6 g/dL (IQR, 10.3 to 12.7 g/dL) in
patients with allogeneic blood transfusion and 11.4 g/dL
(IQR, 10.4 to 12.2 g/dL) in those avoiding transfusion
(P  .74).
DISCUSSION
We described the largest reported series of aortic recon-
structions with an autologous transfusion strategy consist-
ing of ANH and ICS. Transfusion requirements were vir-
tually limited to patients with complications, with 40% of
stored blood given to 11 patients needing second opera-
tions. Some transfusions could have been given in violation
of our transfusion trigger, as shown by a relatively high
hemoglobin concentration in transfused patients on dis-
charge. Because our study was retrospective, identification
of the number of inappropriate transfusions was impossible.
Our results compare well with previously published
series in which stored blood was given to 96% of cases
without autologous transfusion7 and 66% of cases when
ICS was used alone.9 Although the combination of ANH
and ICS was important, we used a restrictive transfusion
trigger, a hemoglobin concentration of 8 to 8.5 g/dL,
which has been adopted in more recent literature.14-16
Furthermore, blood loss measurements were lower than
previously reported.6,17,18 In this series, transfusion re-
quirements were lower than those reported by the recent
Autologous Transfusion in Surgery trial,8 which used the
same autologous transfusion strategy and similar transfu-
sion triggers. In this randomized trial (in which our unit
participated), 43% of the “autologous” patients needed allo-
geneic blood. Our comparatively contained allogeneic trans-
fusion requirements could be the result of attention to oper-
ative blood loss and longer experience with autologous
transfusion techniques. Because intraoperative allogeneic
transfusion was rarely necessitated, and not necessitated at all
in the last 61 patients, we no longer crossmatch allogeneic
blood before elective infrarenal aortic surgery, whether for
aneurysm repair or aortobifemoral bypass. Before surgery, a
blood sample is analyzed for blood grouping and screened for
atypical antibodies in all patients. If allogeneic blood is
needed, blood then can be rapidly crossmatched and trans-
fused within 10 to 15 minutes of request, unless atypical
antibodies are present. In practice, we have not had delays in
transfusing allogeneic blood when this was necessary.
Because all patients underwent ANH and ICS, conclu-
sions about the safety of our transfusion strategy are not
possible. In the recent Autologous Transfusion in Surgery
trial, however, no evidence was seen of increased morbidity
or mortality rates with ANH and ICS.8 A mortality rate of
8% for elective aortic surgery is in line with large multi-
Table III. Outcome of surgery
AAA
(n  78)
ABG
(n  32) P value
Complications 33 (42%) 12 (37%) .8
MI/LVF/arrhythmia 15 (19%) 3 (9%)
Chest “infection” 14 (23%) 1 (3%)
Respiratory failure 4 (5%) 1 (3%)
Hemorrhage 3 (4%) 1 (3%)
Renal failure 7 (9%) 0
Bowel obstruction/perforation 2 (3%) 1 (3%)
Limb ischemia 2 (3%) 2 (6%)
Miscellaneous* 7 (9%) 5 (16%)
Reoperations 7 (9%) 4 (12%) .83
Hemorrhage 3 (4%) 1 (3%)
Limb ischemia 2 (3%) 2 (6%)
Bowel obstruction/perforation 2 (3%) 1 (3%)
Deaths 7 (9%) 2 (6%) .43
MI 5 (6%) 2 (6%)
Multiorgan failure 2 (3%)
Postoperative stay (days)† 9 (8-13) 8 (7-11) .09
*Includes four wound hematomas, one wound infection, two minor strokes, two deep vein thromboses, and three urinary retentions.
†Median (IQR).
AAA, Aneurysm repair; ABG, aortobifemoral bypass; MI, myocardial infarction; LVF, left ventricular failure.
Table II. Blood losses, salvaged red cell volumes, and transfusion requirements
AAA (n  78) ABG (n  32) P value
Blood loss (mL)* 1140 (683-1609) 775 (400-1225) .02
Salvaged red cells (mL)* 403 (256-563) 250 (200-290) .001
Patients transfused (no.) 29 7 .18
Transfusion requirements (units)* 0 (0-2) 0 (0-0) .09
*Median (IQR).
AAA, Aneurysm repair; ABG, aortobifemoral bypass.
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center reviews from the United Kingdom and United
States.19,20 Furthermore, some of our patients were re-
ferred by other vascular surgeons from peripheral hospitals
in view of their preoperative risk, and 10% needed suprare-
nal clamping. Recent reports, however, have shown a low
mortality rate even in patients at high risk and in the
elderly.21 Our restrictive transfusion trigger possibly may
have contributed, in some cases, to the development of
cardiac complications, which occurred in nearly one fifth of
our aneurysm repairs and caused more than three quarters
of our deaths. Only a large study comparing liberal and
restrictive transfusion triggers in aortic surgery, however,
would be able to provide a definite answer to this question.
The efficacy of ANH in blood conservation strategies
has been disputed, mainly on the basis of mathematic model-
ing showing only modest reduction in net hemoglobin loss-
es.22 These models fail to reflect clinical practice, as ANH
blood was reinfused immediately after bleeding started during
surgery. The obvious mechanism by which ANH reduces
transfusion requirements is dilution of intraoperative blood
losses. When ANH is used in combination with ICS, intraop-
erative blood loss is replaced with salvaged red cells, effectively
prolonging the hemodilution period. Furthermore, delaying
reinfusion of ANH blood until wound closure may provide
fresh platelets and clotting factors when hemostasis is most
necessary. Evidence exists that hemodilution associated with
bleeding produces a relative hypercoagulability, which may
reduce further bleeding.23 In this study, differentiation of the
effect of ANH from that of ICS was impossible because all
patients underwent both procedures. A recently published
randomized trial does, however, suggest that ANH signifi-
cantly contributes to reduce allogeneic transfusion in aortic
aneurysm repair.24 Aortobifemoral bypasses were associated
with significantly lower blood losses, yielding smaller volumes
of salvaged red cells, which did not justify routine cell salvage.
Our current practice is to use ANH alone for aortobifemoral
bypass in patients with normal preoperative hemoglobin.
The lack of a control group and the retrospective nature
of this study clearly limit the weight of our conclusions.
However, these results show that the combination of au-
tologous transfusion with restrictive transfusion triggers
and careful surgery render allogeneic blood transfusion
largely unnecessary during infrarenal aortic surgery. Post-
operative transfusion is still necessitated in some patients,
particularly those with complications. Further randomized
trials now are needed to separately evaluate ANH and ICS
as part of a coherent transfusion strategy in moderate and
high blood loss surgery.
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